Log In
BCIQ
Print this Print this
 

Koate-DVI (Antihemophillic Factor)

  Manage Alerts
Collapse Summary General Information
Company Kedrion Group S.p.A.
DescriptionHuman antihemophillic factor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationHemophilia
Indication DetailsTreat hemophilia A
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today